AB
SRNE

Amalgamated Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Amalgamated Bank’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-61,373
Closed -$54K – 2965
2022
Q4 		$54K Buy
61,373
+11,289
+23% +$15K ﹤0.01% 2388
2022
Q3 		$79K Buy
50,084
+145
+0.3% +$329 ﹤0.01% 2261
2022
Q2 		$100K Buy
49,939
+2,519
+5% +$4.36K ﹤0.01% 2170
2022
Q1 		$110K Sell
47,420
-3,738
-7% -$11.7K ﹤0.01% 2159
2021
Q4 		$238K Buy
51,158
+3,001
+6% +$18.6K ﹤0.01% 1911
2021
Q3 		$367K Sell
48,157
-2,069
-4% -$17.5K ﹤0.01% 1748
2021
Q2 		$487K Buy
50,226
+14,592
+41% +$116K ﹤0.01% 1657
2021
Q1 		$295K Sell
35,634
-3,286
-8% -$34.7K 0.01% 1273
2020
Q4 		$266K Buy
38,920
+4,483
+13% +$36K 0.01% 1291
2020
Q3 		$384K Buy
34,437
+6,540
+23% +$59.9K 0.02% 987
2020
Q2 		$175K Buy
27,897
+6,415
+30% +$24.6K 0.01% 1322
2020
Q1 		$40K Buy
21,482
+976
+5% +$2.81K ﹤0.01% 1587
2019
Q4 		$69K Hold
20,506
– – ﹤0.01% 1771
2019
Q3 		$44K Sell
20,506
-178
-0.9% -$415 ﹤0.01% 1721
2019
Q2 		$55K Buy
20,684
+5,666
+38% +$20.4K ﹤0.01% 1740
2019
Q1 		$71K Buy
15,018
+596
+4% +$1.56K ﹤0.01% 1623
2018
Q4 		$35K Buy
+14,422
New +$47.1K ﹤0.01% 1591
2018
Q3 		– Sell
-13,381
Closed -$96K – 1656
2018
Q2 		$96K Buy
+13,381
New +$91K ﹤0.01% 1660

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Amalgamated Bank's SRNE Position: Q1 2023 in Review

Amalgamated Bank sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 61,373 shares — an estimated $54K sold.

Amalgamated Bank first reported a position in SRNE in Q2 2018 and held it in 18 quarters. The position peaked at $487K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Amalgamated Bank reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Amalgamated Bank sold 61,373 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $54K.
  • Amalgamated Bank first reported a position in Sorrento Therapeutics, Inc. in Q2 2018 and held it in 18 quarters.
  • Amalgamated Bank's Sorrento Therapeutics, Inc. position peaked at $487K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Amalgamated Bank's 13F filing for Q1 2023, filed 2 May 2023.